Nano-X Imaging (NNOX) EBITDA (2019 - 2025)

Nano-X Imaging has reported EBITDA for 7 years, with the latest figure at -$33.4 million in Q4 2025.

• For the quarter ending Q4 2025, EBITDA fell 137.13% year-over-year to -$33.4 million; the trailing twelve-month figure through Dec 2025 stood at -$75.0 million (down 40.98% YoY), and the FY2025 full-year result was -$75.0 million, down 40.98% from the prior year.
• EBITDA for Q4 2025 stood at -$33.4 million, down from -$13.7 million in the prior quarter.
• The five-year high for EBITDA was -$9.9 million in Q4 2023, with the low at -$52.4 million in Q4 2022.
• Historically, EBITDA has averaged -$18.2 million across 5 years, with a median of -$13.9 million in 2021.
• Annual changes were most pronounced in 2023 — EBITDA surged 81.08% — and 2025, when it slumped 137.13%.
• Nano-X Imaging's EBITDA stood at -$22.5 million in 2021, then slumped by 133.17% to -$52.4 million in 2022, then surged by 81.08% to -$9.9 million in 2023, then plunged by 42.06% to -$14.1 million in 2024, then tumbled by 137.13% to -$33.4 million in 2025.
• The last three EBITDA figures came in at -$33.4 million (Q4 2025), -$13.7 million (Q3 2025), and -$14.7 million (Q2 2025), per Business Quant data.